top of page

Black Diamond Therapeutics' CEO on the company's 'MasterKey' approach to precision oncology

Mark Velleca describes Black Diamond's 'MasterKey' approach to precision oncology that's aimed at solving many mutations at once, and updates us on lead programs targeting EGFR and BRAF.



Σχόλια


Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

bp-logo.png

Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world. 

bottom of page